Europe — EMA
Nodoryl Forte (Metamizole Sodium Monohydrate)
GNH USA supplies Nodoryl Forte (Metamizole Sodium), an analgesic for mild to moderate pain, fever and post‑operative pain. Request a quote for global supply.
Request sourcing
What is Metamizole Sodium Monohydrate?
Metamizole sodium, the active ingredient in Nodoryl Forte, is a pyrazolone non‑opioid analgesic presented as an oral tablet for oral use. It is employed to relieve mild to moderate pain, reduce fever, and manage postoperative discomfort and colic in adult patients.
GNH USA supplies Nodoryl Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers, including acute care and outpatient settings.
What is Metamizole Sodium Monohydrate used for?
Metamizole sodium is used for pain and fever management by acting on cyclo‑oxygenase pathways.
Mild to moderate pain: Provides analgesic relief in conditions such as musculoskeletal discomfort. Fever: Reduces elevated body temperature in febrile states. Post‑operative pain: Controls pain following surgical procedures. Colic: Alleviates visceral pain associated with intestinal colic.
What are the side effects of Metamizole Sodium Monohydrate?
Metamizole sodium may cause a range of adverse reactions, varying from mild to serious.
Common Side Effects: - Gastrointestinal discomfort: Nausea, abdominal pain or dyspepsia. - Skin reactions: Rash or mild itching. - Dizziness or headache: Transient sensations of light‑headedness. - Transient hypotension: Brief drop in blood pressure after dosing.
Serious or Rare Side Effects: - Agranulocytosis: Severe reduction in white blood cells, potentially life‑threatening. - Anaphylactic reactions: Rapid onset of allergic symptoms including airway compromise. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: Elevated liver enzymes indicating possible liver injury.
What precautions apply to Metamizole Sodium Monohydrate?
When prescribing Metamizole sodium, clinicians should observe several safety measures.
Renal function: Assess kidney status in patients with pre‑existing renal impairment. Hematologic monitoring: Perform regular blood counts to detect early agranulocytosis. Allergy history: Avoid use in individuals with known hypersensitivity to pyrazolones. Concomitant drugs: Use caution with other myelosuppressive agents. Pregnancy and lactation: Evaluate risk‑benefit, as safety data are limited. Store at ambient temperature: Keep below 25 °C in original packaging, protect from moisture.
What does Metamizole Sodium Monohydrate interact with?
Metamizole sodium can interact with several medicines, altering efficacy or safety.
Major Interactions (Avoid): - Cytotoxic chemotherapy: May exacerbate bone‑marrow suppression, increasing risk of agranulocytosis. - Immunosuppressants: Combined effect can further reduce white blood cell counts. - Anticoagulants: Potentially enhance bleeding risk through platelet function changes.
Moderate Interactions (Monitor Closely): - Sulfonamide antibiotics: May increase risk of hypersensitivity reactions. - ACE inhibitors: Possible additive hypotensive effect. - Other NSAIDs: Combined use can raise gastrointestinal toxicity.



